Lacrimal system cancer
diseaseOn this page
Also known as cancer of lacrimal apparatuslacrimal apparatus cancerlacrimal system neoplasmlacrimal system neoplasmslacrimal system tumorlacrimal system tumourmalignant lacrimal apparatus neoplasmmalignant neoplasm of lacrimal apparatusneoplasm of lacrimal systemneoplasm of the lacrimal systemtumor of lacrimal systemtumor of the lacrimal systemtumour of lacrimal systemtumour of the lacrimal system
Summary
Lacrimal system cancer (MONDO:0002460) is a cancer. A subtype of lacrimal apparatus disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | lacrimal system cancer |
| Mondo ID | MONDO:0002460 |
| DOID | DOID:292 |
| ICD-11 | 456911769 |
| NCIT | C5102 |
| SNOMED CT | 416510003 |
| UMLS | C1334361 |
| MedGen | 272790 |
| Anatomy (UBERON) | UBERON:0001750 |
| Is cancer (heuristic) | yes |
Also known as: cancer of lacrimal apparatus · lacrimal apparatus cancer · lacrimal system neoplasm · lacrimal system neoplasms · lacrimal system tumor · lacrimal system tumour · malignant lacrimal apparatus neoplasm · malignant neoplasm of lacrimal apparatus · neoplasm of lacrimal system · neoplasm of the lacrimal system · tumor of lacrimal system · tumor of the lacrimal system · tumour of lacrimal system · tumour of the lacrimal system
Disease family
This is a subtype of lacrimal apparatus disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › lacrimal apparatus disorder › lacrimal system cancer
Related subtypes (16): lacrimal passage granuloma, eversion of lacrimal punctum, stenosis of lacrimal punctum, stenosis of lacrimal passage, excessive tearing, primary lacrimal atrophy, secondary lacrimal atrophy, stenosis of lacrimal sac, acute inflammation of lacrimal passage, chronic inflammation of lacrimal passage, dry eye syndrome, IgG4-related dacryoadenitis and sialadenitis, isolated congenital alacrima, disorder of lacrimal gland, nasolacrimal duct disorder, syndromic lacrimal system disorder
Subtypes (2): lacrimal duct cancer, lacrimal gland cancer
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.